Now accepting a limited number of new Valerian patients each quarter · River Oaks, Houston
Reserve Your Assessment
It has a name,
and it has treatment.
Most women in this program were told at some point that what they were describing was stress, or age, or in their head. It is a recognised clinical entity with published treatment guidance, and it is assessed here through a panel rather than a conversation about how you are coping.
Perimenopause began
before anyone named it.
The transition frequently starts in the early forties and can run for the better part of a decade before anyone uses the word. Cycles may still be regular. Standard labs may still read normal. And in the middle of that, tissue changes, comfort changes, and desire changes, often gradually enough that it gets attributed to everything except the biology producing it.
Declining estradiol affects the tissue directly: thickness, elasticity, natural lubrication, and blood flow all depend on it. That collection of changes has a clinical name, genitourinary syndrome of menopause, and published position guidance identifies hormone therapy as the most effective treatment for it. This is not a fringe conversation. It is simply one most women are never offered.
Desire is a separate question with its own drivers: testosterone, thyroid, sleep, and cortisol all contribute, and they are read in the same panel. Where the hormonal picture is the finding, correcting it is the program rather than an addition to it.
Perimenopausal Change
The years before menopause is formally reached, when estradiol is fluctuating and declining but cycles and standard labs can still read unremarkable.
Tissue Health & Comfort
Dryness, thinning, and discomfort. The genitourinary changes that follow estradiol decline and that respond to treatment rather than requiring endurance.
Decreased Libido
A distinct question from comfort, with its own drivers: testosterone, thyroid, cortisol, and sleep quality all contribute and all get read.
Postpartum Recovery
Where tissue and hormonal recovery has been incomplete well past the point anyone expected it to resolve on its own.
Comfort and desire
are separate findings.
They are frequently present together, and they respond to different things. Establishing which you are dealing with, usually both in some proportion, is the first work of the program.
Comprehensive Panel
Estradiol, progesterone, testosterone, DHEA-S, SHBG, full thyroid including free T3 and reverse T3, and cortisol. Read together, because the interaction between them is what produces how you feel rather than any single value.
The Timing Conversation
Where hormone therapy is appropriate, route, dose, and timing relative to menopause onset all change the benefit-risk picture materially. That is discussed properly before anything is prescribed rather than summarised into reassurance.
Cellular Support Where Indicated
Where tissue quality and vascular responsiveness are the finding rather than the hormonal picture alone, stem cell preparations are used to signal repair in that tissue. Private, outpatient, same sourcing standard as everywhere here.
Reassessed, Not Left Running
Panels at six to eight weeks, then periodic review of whether continuing still makes sense for you. Published guidance calls specifically for periodic reevaluation rather than indefinite continuation, and that is how it is run.
Hormone therapy is prescribed only where clinically indicated following physician evaluation and is not appropriate for everyone. Cellular preparations are investigational and are not FDA-approved for any condition. Published position guidance is available at PubMed (PMID 35797481). Individual results vary.
The reason this went
unaddressed for so long.
Twelve-minute appointments do not accommodate this conversation, and most women learn quickly that raising it produces reassurance rather than investigation. That is a structural problem, and it is one this practice was built to avoid.
Time to Actually Discuss It
Sixty to ninety minutes, unhurried by design. This is not a topic that fits into the last two minutes of an appointment, and it is not one you should have to raise twice.
The Full Panel, Not TSH Alone
Estradiol, progesterone, testosterone, DHEA-S, SHBG, cortisol, and thyroid including free T3 and reverse T3. A workup that stopped at TSH has missed most of what determines how you feel.
An Honest Risk Conversation
Type, dose, route, timing, and your own history all change the picture. You will get the actual complexity rather than either blanket reassurance or blanket caution, both of which are failures of the same kind.
Complete Discretion
Private arrival, private suite, by appointment only, no shared waiting area. Nothing about the visit identifies why you are here.
What Valerian patients ask
before they commit.
Two things are usually going on there. The first is what was measured. A workup covering TSH and little else has missed most of the hormonal picture, and estradiol during perimenopause fluctuates enough that a single reading tells you less than people assume. The second is that "normal range" describes where most women fall rather than where you function. Genitourinary syndrome of menopause is a recognised clinical entity with published treatment guidance, not an inevitability to be absorbed. Whether it applies to you is a question a panel can answer.
Usually both, in some proportion, and they call for different things. Estradiol decline affects tissue thickness, elasticity, natural lubrication, and blood flow directly, and that side frequently responds to hormonal correction. Desire is a separate finding with separate drivers including testosterone, thyroid, cortisol, and sleep quality. And where tissue quality and vascular responsiveness are the limiting factor rather than hormone levels, that is where the cellular side of the program applies. The panel establishes the proportions rather than guessing at them.
You have, and most of the confusion traces to one large study from the early 2000s whose findings were generalised well beyond the population it studied. Current published position guidance is considerably more nuanced. For women under sixty or within ten years of menopause onset, without contraindications, the benefit-risk balance is described as favourable for vasomotor symptoms and genitourinary syndrome of menopause. Beyond that window it is described as less favourable. Risk also varies by type, dose, duration, route, and whether a progestogen is used, which is exactly why guidance calls for individualized decisions. The statement is at PubMed.
No, and this is one of the more common misunderstandings. Perimenopause frequently begins in the early forties and can run for years while cycles remain regular and standard labs read unremarkable. Estradiol fluctuates considerably during that period rather than declining smoothly, which is precisely why a single reading can be misleading and why symptoms often precede any obvious lab finding. Being early in the transition is a reason to establish a baseline, not a reason to wait.
Stem cell preparations signal repair in tissue rather than replacing anything. Where the finding is tissue quality and vascular responsiveness rather than hormone levels alone, that is where it applies. These are investigational applications, not FDA-approved for any condition, and candidacy is a physician determination made from your panel. Sourcing, culture method, and lot verification are covered on the Stem Cells page if you want to know what is in the vial before agreeing to it.
No. Valere operates as a private-pay practice. That is what makes the panel as comprehensive as it is and the appointment as long as it is. An insurance-driven model would not support a full hormonal and thyroid workup for someone whose TSH reads normal, and it certainly would not support the time this conversation actually requires. Payment plans and membership options are available.
You should not have to
raise this twice.
Your assessment includes the full hormonal panel and the time to discuss what it shows. Private, unhurried, and physician-guided throughout.
Reserve Your AssessmentPrivate · By appointment only · River Oaks, Houston